Evaluating The Safety Of Donepezil Hydrochloride (Aricept) For Up To 1 Year In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome - Follow-Up To A 10-Week, Double-Blind, Placebo-Controlled Trial

This study has been terminated.

( Sufficient evidence of efficacy not met. Discontinuation not based on any safety concerns. )

Study NCT00675025 Information provided by Eisai Inc.

First Received: May 7, 2008 Last Updated: December 10, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	February 2009 (Final data collection date for primary outcome measure)